Back to search results
NCT04663724

Computer - Based Treatment for Social Anxiety Disorder

Recruiting
NAAges 18–60InterventionalTreatment
New York State Psychiatric Institute
~80 participants
Updated 2026-06-01 on ClinicalTrials.gov
What's tested:Computer-Based Treatment

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Total Score of Liebowitz Social Anxiety Scale (LSAS)
Measured over From baseline up to Month 4
+1 more outcome measured

Conditions

Social Anxiety Disorder

Explore related trials

Social Anxiety Disorder

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • FRANKLIN SCHNEIER, MD · PRINCIPAL_INVESTIGATOR · New York State Psychiatric Institute

Who to contact

Franklin Schneier, MD
[email protected]
6467748041
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Males and females between the ages of 18 to 60
Current primary diagnosis of SAD
Score of at least 50 on the Liebowitz Social Anxiety Scale (self-rated version)
Fluent in English
Willing and able to give informed written consent
Ability to participate responsibly in the protocol
Normal or corrected-to-normal vision

Exclusion

Present or past psychotic episode, psychotic disorder, schizophrenia, schizoaffective disorder, or bipolar disorder
Current severe depression
Suicidal ideation or behavior
Current diagnosis of post-traumatic stress disorder, obsessive-compulsive disorder, bipolar disorder, manic episode or tic disorder
Current or past organic mental disorder, seizure disorder, epilepsy or brain injury
Current unstable or untreated medical illness
Severe alcohol use disorder, severe cannabis use disorder, and any severity of other substance use disorder (except nicotine use disorders)
Use of psychiatric medication in the past month other than a stable dose of selective serotonin reuptake inhibitors (SSRIs) for at least 3 months
Any concurrent cognitive behavioral therapy or other psychotherapy that was initiated in the past 3 months
Pregnancy, or plans to become pregnant during the period of the study (will be assessed by urine)
Contraindication to MRI scanning (Paramagnetic metallic implants or devices contraindicating magnetic resonance imaging or any other non-removable paramagnetic metal in the body)
Inability to tolerate MRI scanning procedures (i.e., severe obesity, claustrophobia)

What this trial measures

  • Change in Total Score of Liebowitz Social Anxiety Scale (LSAS)From baseline up to Month 4

    Clinician-rated scale scoring anxiety (0, none to 3, severe) and avoidance (0,none to 3, severe) in 24 social situations for a total score of 0 to 144. Higher scores indicate greater social anxiety.

  • Change in Total Score of Quality of Life Enjoyment & Satisfaction QuestionnaireFrom baseline up to Month 4

    Quality of Life Enjoyment \& Satisfaction Questionnaire (Q-LES-Q): self-rated assessment of quality of life. 16 items related to life quality, each rated on a score of 1 (very poor) to 5 (very good), with a minimum total score of 16, and a maximum total score of 80.